Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:863985rdf:typepubmed:Citationlld:pubmed
pubmed-article:863985lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:863985lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:863985lifeskim:mentionsumls-concept:C0003289lld:lifeskim
pubmed-article:863985lifeskim:mentionsumls-concept:C0577559lld:lifeskim
pubmed-article:863985lifeskim:mentionsumls-concept:C1510438lld:lifeskim
pubmed-article:863985lifeskim:mentionsumls-concept:C0439212lld:lifeskim
pubmed-article:863985lifeskim:mentionsumls-concept:C0700456lld:lifeskim
pubmed-article:863985lifeskim:mentionsumls-concept:C0701010lld:lifeskim
pubmed-article:863985pubmed:issue3lld:pubmed
pubmed-article:863985pubmed:dateCreated1977-7-18lld:pubmed
pubmed-article:863985pubmed:abstractTextFor the assay of the antidepressant compound mianserin hydrochloride (Org GB 94) in human plasma, a mass fragmentographic method, using the deuterated analogue as internal standard and a high-performance liquid chromatographie sample clean-up procedure has been developed. The assay specifications obtained are a lower limit for reliable measurements of 1 ng/ml, and accuracy of ca. 0.01 ng/ml, a precision of 6--7% and a capacity of about 60 samples per day. The applicability of the assay method is illustrated by measurements of single-dose and steady-state plasma levels in clinical experiments, demonstrating the possibility of monitoring plasma levels during at least 24 h after a single dose of 15 mg of Org GB 94. The mean steady-state plasma levels after a daily dose of 3 X 20 mg of Org GB 94 appeared to be remarkably constant with time: 38, 36 and 34 ng/ml after 2, 4, and 6 weeks of treatment of 18 depressed patients.lld:pubmed
pubmed-article:863985pubmed:languageenglld:pubmed
pubmed-article:863985pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:863985pubmed:citationSubsetIMlld:pubmed
pubmed-article:863985pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:863985pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:863985pubmed:statusMEDLINElld:pubmed
pubmed-article:863985pubmed:monthMaylld:pubmed
pubmed-article:863985pubmed:issn0021-9673lld:pubmed
pubmed-article:863985pubmed:authorpubmed-author:de RidderJ...lld:pubmed
pubmed-article:863985pubmed:authorpubmed-author:van HalH JHJlld:pubmed
pubmed-article:863985pubmed:authorpubmed-author:KoppensP CPClld:pubmed
pubmed-article:863985pubmed:issnTypePrintlld:pubmed
pubmed-article:863985pubmed:day1lld:pubmed
pubmed-article:863985pubmed:volume143lld:pubmed
pubmed-article:863985pubmed:ownerNLMlld:pubmed
pubmed-article:863985pubmed:authorsCompleteYlld:pubmed
pubmed-article:863985pubmed:pagination289-97lld:pubmed
pubmed-article:863985pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:863985pubmed:meshHeadingpubmed-meshheading:863985-H...lld:pubmed
pubmed-article:863985pubmed:meshHeadingpubmed-meshheading:863985-D...lld:pubmed
pubmed-article:863985pubmed:meshHeadingpubmed-meshheading:863985-M...lld:pubmed
pubmed-article:863985pubmed:meshHeadingpubmed-meshheading:863985-M...lld:pubmed
pubmed-article:863985pubmed:meshHeadingpubmed-meshheading:863985-K...lld:pubmed
pubmed-article:863985pubmed:meshHeadingpubmed-meshheading:863985-A...lld:pubmed
pubmed-article:863985pubmed:meshHeadingpubmed-meshheading:863985-D...lld:pubmed
pubmed-article:863985pubmed:meshHeadingpubmed-meshheading:863985-G...lld:pubmed
pubmed-article:863985pubmed:meshHeadingpubmed-meshheading:863985-M...lld:pubmed
pubmed-article:863985pubmed:year1977lld:pubmed
pubmed-article:863985pubmed:articleTitleMass fragmentographic assay of nanogram amounts of the antidepressant drug mianserin hydrochloride (Org GB 94) in human plasma.lld:pubmed
pubmed-article:863985pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:863985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:863985lld:pubmed